A Comparative Study of the Efficacy of Methylprednisolone Administration Route on Postoperative Sequelae Following Impacted Third Molar Extraction
Keywords:Methylprednisolone Administration; Postoperative Sequelae; Impacted Third Molar Extraction
Background: Surgery on the lower-impacted third molar typically includes injury to the heavily vascularized
loose connective tissue due to its anatomical location, leading to inflammatory sequelae during the immediate
post-operative stage, including postoperative pain, oedema and trismus.
Aims: This prospective, randomized, comparative clinical study was conducted in 30 patients to assess pain,
oedema and trismus in patients undergoing surgical removal of impacted third molars.
Method: The study sample involves 30 patients, randomly categorized into 3 groups: group 1 (control;
no steroids), group 2 (Intra-Muscular injection in Masseter muscle), group 3 (oral tablets). Patient aged
between 18 and 30, with a similar anatomical position, and similar surgical difficulty, no allergies, without
any systemic diseases are included. Syndromic patients, patients with periapical pathologies were excluded
from the study. A single surgeon was working on all patients using a standard technique. On the 2nd
and 7th postoperative day, linear oedema and maximal mouth opening were evaluated for both routes of
methylprednisolone administration and compared.
Results: We observed a higher range of mouth opening found in masseter injection group relative to the
oral tablet group on Day 2 & 7, for the steroid treatment groups. On postoperative days 2 and 7, the overall
increase in the tragus-commissure, canthus-gonion and tragus-pogonion lines, for control & oral tablet
groups were identical and higher than the masseter injection group.
Conclusion: Comparison to the control group following lower third molar surgery, intramassetric injection
provided improved outcomes than tablet form in limiting oedema and trismus
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions